RoPE评分估计的可归因分数与卵圆孔未闭封堵获益相关:3项试验分析
该研究汇总CLOSURE-I、RESPECT和PC三项随机试验数据,分析RoPE评分估计的PFO可归因分数与封堵治疗效应之间的关系。结果显示,高RoPE评分(≥7)患者封堵后复发性卒中风险显著降低(HR 0.31,95%CI 0.11-0.85,P=0.02),而低评分组无显著获益;RoPE估计的可归因分数与相对风险降低高度相关(3项试验r=0.95,P<0.001)。
要点
- 高RoPE评分(≥7)患者封堵治疗显著降低复发性卒中风险。
- 低RoPE评分(<7)患者封堵治疗未见显著获益。
- RoPE估计的可归因分数与封堵的相对风险降低高度相关。
核心结论
- RoPE评分估计的可归因分数与装置封堵相对于药物治疗的相对风险降低高度相关,提示RoPE评分可识别隐源性卒中患者中PFO可能为致病性而非偶然发现。
研究设计与样本
- 汇总CLOSURE-I、RESPECT和PC三项随机试验数据,比较不同RoPE评分水平下封堵治疗与药物治疗的效应。
主要发现
- 低RoPE评分组(<7,n=912)复发性卒中率:装置组1.37/100人年 vs 药物组1.68/100人年(HR 0.82,95%CI 0.42-1.59,P=0.56)。
- 高RoPE评分组(≥7,n=1221)复发性卒中率:装置组0.30/100人年 vs 药物组1.03/100人年(HR 0.31,95%CI 0.11-0.85,P=0.02)。
- 治疗与RoPE评分组交互作用P=0.12。
- RoPE评分估计的可归因分数预测各水平相对风险降低:3项试验分析r=0.95(P<0.001),2项试验分析r=0.92(P<0.001)。
关键数值与推荐
- 高RoPE评分定义为≥7分,低RoPE评分定义为<7分。
- 采用PC试验兼容的9分RoPE方程(省略神经影像变量)估计可归因分数,并采用原始10分RoPE方程进行2项试验分析。
临床怎么用
- RoPE评分可用于识别隐源性卒中患者中PFO可能为致病性的个体,从而指导封堵治疗决策。
局限性
- 本研究为三项随机试验数据的汇总分析,结果需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: In patients with cryptogenic stroke and patent foramen ovale (PFO), the Risk of Paradoxical Embolism (RoPE) Score has been proposed as a method to estimate a patient-specific "PFO-attributable fraction"-the probability that a documented PFO is causally-related to the stroke, rather than an incidental finding. The objective of this research is to examine the relationship between this RoPE-estimated PFO-attributable fraction and the effect of closure in 3 randomized trials. METHODS: We pooled data from the CLOSURE-I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack due to Presumed Paradoxical Embolism through a Patent Foramen Ovale), RESPECT (Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment), and PC (Clinical Trial Comparing Percutaneous Closure of Patent Foramen Ovale [PFO] Using the Amplatzer PFO Occluder With Medical Treatment in Patients With Cryptogenic Embolism) trials. We examine the treatment effect of closure in high RoPE score (≥7) versus low RoPE score (<7) patients. We also estimated the relative risk reduction associated with PFO closure across each level of the RoPE score using Cox proportional hazard analysis. We estimated a patient-specific attributable fraction using a PC trial-compatible (9-point) RoPE equation (omitting the neuroradiology variable), as well as a 2-trial analysis using the original (10-point) RoPE equation. We examined the Pearson correlation between the estimated attributable fraction and the relative risk reduction across RoPE strata. RESULTS: In the low RoPE score group (<7, n=912), the rate of recurrent strokes per 100 person-years was 1.37 in the device arm versus 1.68 in the medical arm (hazard ratio, 0.82 [0.42-1.59] P=0.56) compared with 0.30 versus 1.03 (hazard ratio, 0.31 [0.11-0.85] P=0.02) in the high RoPE score group (≥7, n=1221); treatment-by-RoPE score group interaction, P=0.12. The RoPE score estimated attributable fraction anticipated the relative risk reduction across all levels of the RoPE score, in both the 3-trial (r=0.95, P<0.001) and 2-trial (r=0.92, P<0.001) analyses. CONCLUSIONS: The RoPE score estimated attributable fraction is highly correlated to the relative risk reduction of device versus medical therapy. This observation suggests the RoPE score identifies patients with cryptogenic stroke who are likely to have a PFO that is pathogenic rather than incidental.
引用
- Kent DM, Saver JL, Ruthazer R, et al. Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials. Stroke. 2020. PMID: 32921262. doi:10.1161/STROKEAHA.120.029350
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。